In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1851 News Items found
Postdoctoral researchers discuss a poster presentation
Work of Postdoctoral Researchers Spotlighted at Third Annual Symposium

Each year since 2007, Memorial Sloan Kettering's postdoctoral researchers have had the opportunity to showcase their research accomplishments at the annual Postdoctoral Research Symposium.
Simon Powell
An Interview With Simon Powell

Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program.
Francis M. Sirotnak
FDA Approves Lymphoma Drug Developed at Memorial Sloan Kettering

Patients with a rare but aggressive form of cancer now have access to a drug that has proven effective after the disease becomes resistant to standard treatments.
James Allison
Researchers Design More Effective Cancer Vaccine

Memorial Sloan Kettering investigators have shown that a new type of cancer vaccine might be more effective than previous therapies at inducing immune cells to destroy tumors.
Experimental Breast Cancer Drug Shows Promise in Aggressive Form of Disease

Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.
Dinshaw Patel (left) and David Allis
Linking Histones and Cancer

Structural biologists at Memorial Sloan Kettering Cancer Center are collaborating with biochemists and cell biologists at The Rockefeller University to study how cells read genetic instructions imprinted on histones, DNA's packaging proteins.
Charles Sawyers (left) and Howard Scher
Advances in Development of New Targeted Therapy for Prostate Cancer Show Promise

A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.
Dinshaw J. Patel
Dinshaw Patel Elected to the National Academy of Sciences

Dinshaw J. Patel, a Member in Sloan Kettering Institute's Structural Biology Program and incumbent of the Abby Rockefeller Mauzé Chair in Experimental Therapeutics, was elected to the National Academy of Sciences at its 146th annual meeting in April.
Jennifer A. Zallen
Jennifer Zallen Selected as Early Career Scientist By Howard Hughes Medical Institute

Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist.
Memorial Sloan Kettering President Attends White House Signing

Memorial Sloan Kettering President Harold Varmus joined lawmakers, scientists, and patients on March 9 at a White House ceremony as President Barack Obama issued an executive order lifting the strict limits on human embryonic stem cell research.